Home Journals Articles Updates About
CN
image
收藏切换
Anti-tumour Mechanism of Astragaloside Ⅳ and Its Research Progress in Lung Cancer
收藏切换
Zhenyao YANG1, Xiaoqing ZHANG2, Chengzhi WANG1, Shan ZAHNG1, Gelei ZHAO1, Peimin LIU1, Dongdong LI1
Chinese Archives of Traditional Chinese Medicine | 2025, 43(4) : 187 - 192
Less
收藏切换
Chinese Archives of Traditional Chinese Medicine | 2025, 43(4): 187-192
• Target on National Project •
Anti-tumour Mechanism of Astragaloside Ⅳ and Its Research Progress in Lung Cancer
Full
Zhenyao YANG1, Xiaoqing ZHANG2, Chengzhi WANG1, Shan ZAHNG1, Gelei ZHAO1, Peimin LIU1, Dongdong LI1
Affiliations
  • 1.The Second Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450002, Henan, China
  • 2.The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China
Published: 2025-04-10 doi: 10.13193/j.issn.1673-7717.2025.04.030
Outline
收藏切换

Cancer is the second leading cause of death worldwide，and lung cancer is one of the malignant tumours with the fastest growing morbidity and mortalit and the greatest threat to people＇s health and lives. In recent years，the research on active ingredients of traditional Chinese medicine to prevent and treat tumours has become more and more in-depth. Huangqi（Astragali Radix）is one of the commonly used anti-tumour Chinese medicines，which has been used in medicine for more than 2000 years，and has been regarded as“the most important medicine for replenishing Qi and spleen”. Astragaloside Ⅳ（AS-Ⅳ）is one of the main active ingredients of Huangqi（Astragali Radix），and modern pharmacological studies have shown that AS-Ⅳ has anticancer，anti-inflammatory，antioxidant and immunomodulatory effects. This paper reviewed the research progress of AS-Ⅳ in lung cancer by collecting and summarizing the mechanisms of AS-Ⅳ in inhibiting tumor cell proliferation，inducing tumor cell apoptosis，inhibiting tumor cell migration and invasion，suppressing epithelial-mesenchymal transition（EMT），regulating autophagy，modulating immune response，alleviating toxic side effects during tumor treatment and enhancing sensitivity to antitumor drugs. The aim was to provide a reference for further research，development and application of AS-Ⅳ in order to support its clinical use.

astragalosideⅣ  /  lung cancer  /  mechanism of action
杨振耀, 张晓青, 王成志, 张山, 赵戈蕾, 刘培民, 李东东. 黄芪甲苷抗肿瘤机制及其在肺癌中的研究进展. 中华中医药学刊, 2025 , 43 (4) : 187 -192 . DOI: 10.13193/j.issn.1673-7717.2025.04.030
Zhenyao YANG, Xiaoqing ZHANG, Chengzhi WANG, Shan ZAHNG, Gelei ZHAO, Peimin LIU, Dongdong LI. Anti-tumour Mechanism of Astragaloside Ⅳ and Its Research Progress in Lung Cancer[J]. Chinese Archives of Traditional Chinese Medicine, 2025 , 43 (4) : 187 -192 . DOI: 10.13193/j.issn.1673-7717.2025.04.030
Appendix
Less
Year 2025 volume 43 Issue 4
30
10
Cite this Article
BibTeX
Article Info
doi: 10.13193/j.issn.1673-7717.2025.04.030
  • Online Date：2026-10-30
  • Published：2025-04-10
Article Data
Affiliations
History
Funding
Affiliations
    1.The Second Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450002, Henan, China
    2.The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China
References
Share
https://castjournals.cast.org.cn/joweb/zhzyyxk/EN/10.13193/j.issn.1673-7717.2025.04.030
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House